Stockscreener 앱 받기
23.50
4.97%
-1.23
전일 마감가:
$24.73
열려 있는:
$24.65
하루 거래량:
1.21M
Relative Volume:
1.37
시가총액:
$1.29B
수익:
$199.89M
순이익/손실:
$52.48M
주가수익비율:
27.65
EPS:
0.85
순현금흐름:
$61.15M
1주 성능:
+3.84%
1개월 성능:
+18.93%
6개월 성능:
+253.38%
1년 성능:
+91.21%
1일 변동 폭
$23.25
$24.97
1주일 범위
$21.87
$24.97
52주 변동 폭
$5.35
$24.97
Stoke Therapeutics Inc Stock (STOK) Company Profile
명칭
Stoke Therapeutics Inc
전화
781-430-8200
주소
45 WIGGINS AVENUE, BEDFORD, MA
STOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STOK
Stoke Therapeutics Inc
|
23.50 | 1.36B | 199.89M | 52.48M | 61.15M | 0.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Stoke Therapeutics Inc Stock (STOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-18 | 개시 | Jefferies | Buy |
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-10-14 | 재개 | Leerink Partners | Outperform |
| 2024-03-26 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-07-25 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-05-01 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-26 | 재개 | Canaccord Genuity | Buy |
| 2023-01-06 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-10-24 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-01-31 | 개시 | Jefferies | Buy |
| 2021-12-03 | 개시 | BofA Securities | Buy |
| 2021-11-22 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-18 | 개시 | UBS | Neutral |
| 2021-05-10 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-02-10 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-12-15 | 재개 | H.C. Wainwright | Buy |
| 2020-12-11 | 재확인 | Needham | Buy |
| 2020-10-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-09-29 | 개시 | Needham | Buy |
| 2019-12-18 | 개시 | Wedbush | Outperform |
| 2019-11-12 | 개시 | BTIG Research | Buy |
| 2019-10-25 | 개시 | H.C. Wainwright | Buy |
| 2019-07-15 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Cowen | Outperform |
| 2019-07-15 | 개시 | Credit Suisse | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
모두보기
Stoke Therapeutics Inc 주식(STOK)의 최신 뉴스
Will Stoke Therapeutics Inc. stock gain from lower inflationEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
Stoke Therapeutics Reaches Analyst Target Price - Nasdaq
Why Stoke Therapeutics Inc. stock is a must watch in 20252025 Bull vs Bear & AI Forecasted Stock Moves - newser.com
How to interpret RSI for Stoke Therapeutics Inc. stockWeekly Trade Analysis & Verified Trade Idea Suggestions - newser.com
Analyzing recovery setups for Stoke Therapeutics Inc. investorsJuly 2025 Selloffs & Low Volatility Stock Recommendations - newser.com
Stoke Therapeutics (NASDAQ:STOK) Sets New 52-Week HighHere's Why - MarketBeat
Using flow based indicators on Stoke Therapeutics Inc.Profit Target & Low Risk Entry Point Guides - newser.com
Stoke Therapeutics stock hits 52-week high at 24.72 USD - Investing.com
Stoke Therapeutics Inc.’s volatility index tracking explainedBond Market & Fast Gain Swing Trade Alerts - newser.com
Quantitative breakdown of Stoke Therapeutics Inc. recent moveQuarterly Risk Review & Low Drawdown Trading Strategies - newser.com
Risk adjusted return profile for Stoke Therapeutics Inc. analyzed2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Is Stoke Therapeutics Inc a good long term investmentSector Performance Review & Exceptional Return Capital - earlytimes.in
Stoke Therapeutics (NASDAQ:STOK) Trading Up 4.9%Still a Buy? - MarketBeat
Assenagon Asset Management S.A. Sells 421,630 Shares of Stoke Therapeutics, Inc. $STOK - MarketBeat
Stoke Therapeutics to Present at Upcoming Investor Conferences in September 2025 | News | postregister.com - FinancialContent
Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 5.1%Here's Why - MarketBeat
First Week of May 2026 Options Trading For Stoke Therapeutics (STOK) - Nasdaq
Fundamentals Check: Should I hold or sell Stoke Therapeutics Inc nowJuly 2025 Technicals & Long-Term Growth Stock Strategies - خودرو بانک
Stop Loss: Why is Stoke Therapeutics Inc. stock going up2025 Stock Rankings & Free Technical Confirmation Trade Alerts - خودرو بانک
Long term hold vs stop loss in Stoke Therapeutics Inc.Market Trend Summary & Accurate Trade Setup Notifications - newser.com
Portfolio Shifts: Is Stoke Therapeutics Inc stock a good pick for beginners2025 Short Interest & Real-Time Market Sentiment Alerts - خودرو بانک
Aug Technicals: Can CERO deliver consistent dividendsMarket Risk Report & Community Supported Trade Ideas - khodrobank.com
Brokerages Set Stoke Therapeutics, Inc. (NASDAQ:STOK) PT at $25.57 - MarketBeat
Is Stoke Therapeutics Inc in a long term uptrendWeekly Trend Report & Expert Curated Trade Setup Alerts - خودرو بانک
Retail Surge: What is the implied volatility of Scholastic CorporationJuly 2025 Review & Risk Managed Trade Strategies - khodrobank.com
Ideas Watch: Is Stoke Therapeutics Inc a cyclical or defensive stock2025 Market Outlook & Accurate Buy Signal Notifications - khodrobank.com
Biogen and Stoke Therapeutics collaborates to develop Dravet syndrome treatment globally - MSN
Pharma News: Is Celldex Therapeutics Inc impacted by rising ratesGap Up & Long Hold Capital Preservation Plans - khodrobank.com
Published on: 2025-09-18 21:42:43 - newser.com
MACD Signal: What hedge funds are buying Stoke Therapeutics IncJuly 2025 Market Mood & Community Verified Watchlist Alerts - خودرو بانک
Jacobs Levy Equity Management Inc. Purchases Shares of 357,248 Stoke Therapeutics, Inc. $STOK - MarketBeat
Siren L.L.C. Raises Position in Stoke Therapeutics, Inc. $STOK - MarketBeat
Is Stoke Therapeutics Inc. forming a bottoming base2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Stoke Therapeutics announces inducement grants under Nasdaq listing - MarketScreener
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
Market Trends: Will Stoke Therapeutics Inc outperform its industry peersWeekly Trade Review & Trade Opportunity Analysis - خودرو بانک
Aug Sentiment: Will Stoke Therapeutics Inc outperform during market ralliesJuly 2025 Update & Safe Capital Growth Stock Tips - خودرو بانک
Pullback Watch: Is TXNM exposed to political riskWeekly Volume Report & Daily Oversold Bounce Ideas - khodrobank.com
Chipmakers Recap: Is Stoke Therapeutics Inc a cyclical or defensive stockJuly 2025 Rallies & Entry Point Strategy Guides - khodrobank.com
Macro Review: Will Stepan Company stock recover after earningsQuarterly Performance Summary & Reliable Price Breakout Alerts - خودرو بانک
Aug Rallies: Is Stoke Therapeutics Inc a strong candidate for buy and holdGold Moves & Free Community Supported Trade Ideas - خودرو بانک
Stop Loss: Is Stoke Therapeutics Inc. stock a buy or sellJuly 2025 Summary & Consistent Return Investment Signals - خودرو بانک
Resistance Check: What dividend growth rate does Stoke Therapeutics Inc offer2025 Historical Comparison & Step-by-Step Trade Execution Guides - خودرو بانک
Meme Stocks: What are the analyst revisions for MESAIs Stoke Therapeutics Inc. stock a good investment in YEARMarket Trend Review & Breakout Confirmation Alerts - خودرو بانک
Growth Value: Will Stoke Therapeutics Inc outperform its industry peers2025 Market WrapUp & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Trade Report: What are the analyst revisions for MESAIs Stoke Therapeutics Inc stock a good investment in YEARJuly 2025 PostEarnings & Community Driven Trade Alerts - خودرو بانک
Stoke Therapeutics (NASDAQ:STOK) Reaches New 52-Week HighTime to Buy? - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Shares Down 5.4%Should You Sell? - MarketBeat
Stoke Therapeutics, Inc. $STOK Shares Sold by Trexquant Investment LP - MarketBeat
Stoke Therapeutics, Inc. $STOK Shares Acquired by Invesco Ltd. - MarketBeat
Stoke Therapeutics Inc (STOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):